Xcel Energy Foundation Celebrates 25 Years of Community Investment

MINNEAPOLIS--(BUSINESS WIRE)--Aug 6, 2026--

The Xcel Energy Foundation today announced it has invested nearly $160 million over the past quarter of a century to strengthen communities, according to a new Impact Report commemorating the Foundation’s 25 th anniversary.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806489730/en/

Since the Foundation’s establishment in 2001, Xcel Energy and the Xcel Energy Foundation have supported communities in Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas and Wisconsin. The investments include more than $82.8 million in grant funding to local nonprofit organizations and $73.6 million in contributions from Xcel Energy employees and retirees through gift matching and volunteer-driven giving programs.

“As we celebrate the Foundation’s 25 th anniversary, this report reflects the incredible impact Xcel Energy and employees made hand-in-hand with our nonprofit partners and communities,” said Patricia Correa, senior vice president, human resources and employee services, and chief human resources officer. “The report honors the work that has shaped our communities for 25 years and our commitment to furthering this impact for decades to come.”

The report highlights the Foundation’s investments to support nonprofit organizations and programs aligned with three core focus areas: community vitality, environmental sustainability and STEM career pathways. In 2025 alone, the Foundation awarded nearly $5 million to 384 nonprofit organizations through its Energizing the Future focus area grant program.

Additional 2025 highlights include:

The report also spotlights nonprofit partner organizations that are making a meaningful difference across the region, including Children’s Theatre Company in Minnesota, The Park People in Colorado, Amarillo College Foundation in Texas, Casakids in New Mexico, North Dakota State University Foundation in North Dakota, Gogebic Community College Foundation in Michigan and Wild Rivers Conservancy of the St. Croix and Namekagon in Minnesota and Wisconsin.

“NDSU Foundation is deeply grateful for the enduring partnership of the Xcel Energy Foundation,” said John Glover, president and CEO, NDSU Foundation, which has received $535,000 in investment from the Xcel Energy Foundation over the past 40 years. “For decades, the investments have expanded opportunity, fueled innovation and empowered generations of NDSU students to transform their potential into impact. The continued commitment strengthens NDSU and the future leaders we serve.”

Beyond grantmaking, the Foundation’s Impact Report showcases how employees support communities through volunteerism, board service and charitable giving.

Read the Xcel Energy Foundation’s 25 th Anniversary Impact Report.

About Xcel Energy

Xcel Energy (NASDAQ: XEL) is a leading energy provider, dedicated to serving millions of customers with excellence. We make energy work better for customers, helping them thrive every day. That means always raising the bar — delivering better service and providing more reliable, resilient and sustainable energy.

We are committed to leading the clean energy transition, meeting our customers’ need for more, cleaner power, while keeping bills as low as possible. Because the people we serve depend on us to power their lives.

Headquartered in Minneapolis, we work every day to generate and distribute electricity and gas to customers across eight states: Minnesota, Colorado, Wisconsin, Michigan, North Dakota, South Dakota, New Mexico and Texas. For more information, visit xcelenergy.com or follow us on X and Facebook.

About Xcel Energy Foundation

The Xcel Foundation is a 501(c)(3) organization that awards charitable grants to nonprofit organizations and sponsors the volunteer programs of Xcel Energy and its subsidiaries. The majority of Xcel Energy Foundation funding comes from Xcel Energy shareholder dollars. Learn more about the Foundation’s Focus Area Grants.

An Xcel Energy volunteer performs community service work.

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said.

The shot, named mFlusiva, is intended for adults age 50 or older. Other brands of flu shots already have begun arriving in pharmacies ahead of fall vaccination season, and Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.

While there already are multiple flu vaccine options in the U.S., including three specifically recommended for people age 65 or older, tens of thousands of Americans die from influenza every year and older adults are among the most vulnerable.

Flu vaccines must be updated annually to best match circulating strains of the virus. Vaccines made with the Nobel Prize-winning mRNA technology are faster to manufacturer than other types, and experts say this additional option might help if the shape-shifting flu virus mutates in a way that requires suddenly brewing new doses.

Moderna said the FDA granted full approval for mFlusiva’s use in people ages 50 to 64, based on a study of 40,000 people that found 27% fewer flu cases among people who got the new shot compared with those who got a different common flu vaccine brand. For people 65 or older, the Cambridge, Massachusetts-based manufacturer said the FDA granted what’s called accelerated approval for the shot -- based on a smaller study showing it generated a strong immune response compared with an existing high-dose vaccine for seniors – while it conducts an additional study.

Moderna’s data showed no major safety issues although the shot did cause some temporary reactions including injection site pain, fever, headache, tiredness and aches that occurred somewhat more than with today’s flu shots.

The FDA action comes after a highly unusual public dispute over mFlusiva earlier this year. A then-top FDA official blocked the company’s application, a sign of the agency’s heightened vaccine scrutiny under Health Secretary Robert F. Kennedy Jr. Days later, the agency changed course after Moderna publicly challenged the ruling — and in June a panel of independent advisers to the FDA unanimously recommended the vaccine's approval.

Follow the AP's coverage of the U.S. Food and Drug Administration at https://apnews.com/hub/us-food-and-drug-administration.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)